Clinical Trials Directory

Trials / Unknown

UnknownNCT01535534

Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis

Evaluation of Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis

Status
Unknown
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
Universitätsmedizin Mannheim · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

During the past years many investigators have focused on the immunological changes in sepsis disease, and great attention has been paid to the development of practicable means of immunomonitoring. Little is known about diagnostic and prognostic vascular biomarkers during the time course of patients with sepsis.

Detailed description

Primary Outcome Measures: New diagnostic and prognostic markers for septic patients Estimated Enrollment: 300 patients Study Start Date: January 2012 Estimated Study Completion Date: open Estimated Primary Completion Date: open Intervention Details: Procedure: vein puncture comparison of different inflammatory markers in the blood of septic patients

Conditions

Timeline

Start date
2012-01-01
Primary completion
2018-12-01
Completion
2021-12-01
First posted
2012-02-17
Last updated
2020-08-27

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01535534. Inclusion in this directory is not an endorsement.

Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis (NCT01535534) · Clinical Trials Directory